Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer ...

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

Pancreatic cancer is mostly pancreatic ductal adenocarcinoma, with late-stage detection due to non-specific symptoms like jaundice and abdominal pain. Diagnosis involves imaging tests, biopsies, and ...

When people ask "is cancer a genetic disease?" they are often thinking about family history: if my parent had cancer, will I? The short answer is complicated but important: cancer is driven by genetic ...

Marcy Richardson from Ambry Genetics discusses the importance of a new study that assessed the functional impact of thousands of BRCA2 variants, identifying those that may increase cancer risk. What ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

Thyroid cancer represents the most common endocrine malignancy, and its genetic underpinnings are increasingly being elucidated through advanced genomic methodologies. Research in this area has ...

PHILADELPHIA, PA & CARLSBAD, CA — Fox Chase Cancer Center and Arima Genomics, Inc. have launched a first-of-its-kind ...

CariGenetics has begun enrolment into its multi-country Caribbean prostate cancer study and is calling on Bermudian men to participate. The Caribbean Prostate Cancer Genetic Study brings the genetics ...